We are live on
!
Find out more
CA
Continuum Advisory Portfolio holdings
AUM
$1.04B
1-Year Est. Return
21.13%
This Fund
S&P 500
This Quarter
Est. Return
+2.72%
1 Year Est. Return
+21.13%
3 Year Est. Return
+59.21%
5 Year Est. Return
+68.09%
10 Year Est. Return
–
AUM
$999M
AUM Growth
+$52.6M
(+5.6%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
3.35%
Top 10 Holdings %
Top 10 Hldgs %
27.71%
Holding
477
New
40
Increased
224
Reduced
163
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$5.52M |
| 2 |
Cigna
CI
|
+$5.18M |
| 3 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$3.88M |
| 4 |
Microsoft
MSFT
|
+$3.59M |
| 5 |
Booz Allen Hamilton
BAH
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$4.79M |
| 2 |
Comcast
CMCSA
|
+$4.09M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$3.54M |
| 4 |
Simplify MBS ETF
MTBA
|
+$1.89M |
| 5 |
Janus Henderson B-BBB CLO ETF
JBBB
|
+$1.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.82% |
| 2 | Healthcare | 5.54% |
| 3 | Financials | 4.29% |
| 4 | Consumer Discretionary | 3.39% |
| 5 | Communication Services | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
IBM
IBM
$211B
| $1.52M | 0.15% |
5,119
+139
| +3% | +$41.6K |
|
127
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $1.5M | 0.15% |
27,968
-905
| -3% | -$49.2K |
|
128
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $1.5M | 0.15% |
31,885
| – | – |
|
|
ARTY
129
iShares Future AI & Tech ETF
ARTY
$3.49B
| $1.49M | 0.15% |
30,908
+2,013
| +7% | +$97K |
|
130
Philip Morris
PM
$297B
| $1.47M | 0.15% |
9,159
-359
| -4% | -$55.6K |
|
131
nVent Electric
NVT
$24.9B
| $1.46M | 0.15% |
14,325
-2,203
| -13% | -$229K |
|
132
First Trust Rising Dividend Achievers ETF
RDVY
$24.7B
| $1.45M | 0.14% |
20,817
+7,463
| +56% | +$507K |
|
|
SCHV
133
Schwab US Large-Cap Value ETF
SCHV
$15.7B
| $1.44M | 0.14% |
48,714
+859
| +2% | +$25.1K |
|
134
Duke Energy
DUK
$97.8B
| $1.44M | 0.14% |
12,270
-155
| -1% | -$18.9K |
|
135
Thermo Fisher Scientific
TMO
$213B
| $1.43M | 0.14% |
2,469
+310
| +14% | +$175K |
|
136
Schwab International Equity ETF
SCHF
$66.6B
| $1.43M | 0.14% |
59,438
+6,040
| +11% | +$144K |
|
137
Palantir
PLTR
$295B
| $1.42M | 0.14% |
7,995
+165
| +2% | +$29.9K |
|
138
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $1.38M | 0.14% |
17,855
-1,897
| -10% | -$145K |
|
139
Intuitive Surgical
ISRG
$127B
| $1.38M | 0.14% |
2,442
-30
| -1% | -$16K |
|
140
Cisco
CSCO
$457B
| $1.38M | 0.14% |
17,908
+3,057
| +21% | +$227K |
|
|
SCHW
141
Charles Schwab
SCHW
$183B
| $1.38M | 0.14% |
13,772
-1,143
| -8% | -$108K |
|
142
SPDR Gold MiniShares Trust
GLDM
$27.5B
| $1.37M | 0.14% |
16,061
-1,078
| -6% | -$88.6K |
|
143
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $1.37M | 0.14% |
27,610
+1,203
| +5% | +$60.2K |
|
144
iShares S&P 500 Growth ETF
IVW
$73.8B
| $1.35M | 0.14% |
10,982
+1,337
| +14% | +$164K |
|
145
Wells Fargo
WFC
$261B
| $1.35M | 0.13% |
14,459
-363
| -2% | -$31.5K |
|
146
Innovator US Equity Power Buffer ETF August
PAUG
$861M
| $1.34M | 0.13% |
30,933
| – | – |
|
147
Verizon
VZ
$195B
| $1.33M | 0.13% |
32,743
-252
| -0.8% | -$10.2K |
|
148
Capital One
COF
$128B
| $1.33M | 0.13% |
5,493
+352
| +7% | +$78.4K |
|
149
Cintas
CTAS
$81.9B
| $1.32M | 0.13% |
7,032
+138
| +2% | +$26K |
|
150
NextEra Energy
NEE
$181B
| $1.31M | 0.13% |
16,305
-448
| -3% | -$37.1K |
|
Similar funds
CIA
CCP
CGA
HWCM
SM
RC
OPFM
WP
Continuum Advisory's Q4 2025 Portfolio in Review
As of Q4 2025, Continuum Advisory held 477 positions worth $999M, up 5.6% from $946M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Continuum Advisory deployed $33.5M of net new capital in Q4 2025, opening 40 new positions and adding to 224 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 101,420 shares worth $6.03M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Comcast, an estimated $4.09M trimmed.
- Continuum Advisory's largest Q4 2025 buy was BioMarin Pharmaceuticals: 101,420 shares worth $6.03M.
- Continuum Advisory added most to PIMCO Multi Sector Bond Active ETF in Q4 2025, an estimated $3.88M increase.
- Continuum Advisory's biggest Q4 2025 reduction was Comcast, cutting an estimated $4.09M.
- Continuum Advisory fully exited Humana in Q4 2025, selling an estimated $4.79M.
- Continuum Advisory's ten largest holdings make up 28% of its $999M portfolio in Q4 2025.
- Continuum Advisory opened 40 new positions and closed 21 in Q4 2025.
- Continuum Advisory's portfolio value rose 5.6% quarter-over-quarter to $999M.
Based on Continuum Advisory's 13F filing for Q4 2025, filed 11 Feb 2026.